Eli Lilly's troubled NJ manufacturing site in hot water again over maintenance, quality control lapses
Eli Lilly's troubled NJ manufacturing site in hot water again over maintenance, quality control lapses fkansteiner Mon, 01/22/2024 - 11:08
Eli Lilly's troubled NJ manufacturing site in hot water again over maintenance, quality control lapses fkansteiner Mon, 01/22/2024 - 11:08
Coherus sells Lucentis biosim to Sandoz for $170M to focus on oncology kdunleavy Mon, 01/22/2024 - 10:53
J&J's Balversa gets mixed approval in bladder cancer as FDA ratchets up scrutiny on subgroup data, patient survival aliu Mon, 01/22/2024 - 10:28
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff zbecker Mon, 01/22/2024 - 09:29